Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Khris Smith who wrote (11485)	9/6/2012 7:43:35 AM
From: Howard Williams	Read Replies (1) \| Respond to of 13111

KNOXVILLE, Tenn., Sep 06, 2012 (BUSINESS WIRE) -- Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, pvct.com ), a development-stage oncology and dermatology biopharmaceutical company, will present at the Rodman & Renshaw 14th Annual Healthcare Conference in New York City on September 11, 2012 at 2:00 p.m. EDT, at The Waldorf-Astoria. Peter Culpepper, Chief Financial Officer and Chief Operating Officer of Provectus, will be delivering the presentation. A live webcast of the presentation will be available at the following link and will be available for 90 days: wsw.com